Standard
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study. / Casabonne, Delphine; Benavente, Yolanda; Seifert, Julia; Costas, Laura; Armesto, Maria; Arestin, Maria; Besson, Caroline; Hosnijeh, Fatemeh S.; Duell, Eric J.; Weiderpass, Elisabete; Masala, Giovanna; Kaaks, Rudolf; Canzian, Federico; Chirlaque, Maria-Dolores; Perduca, Vittorio; Mancini, Francesca R.; Pala, Valeria; Trichopoulou, Antonia; Karakatsani, Anna; La Vecchia, Carlo; Sanchez, Maria-Jose; Tumino, Rosario; Gunter, Marc J.; Amiano, Pilar; Panico, Salvatore; Sacerdote, Carlotta; Schmidt, Julie A.; Boeing, Heiner; Schulze, Matthias B.; Barricarte, Aurelio; Riboli, Elio; Olsen, Anja; Tjønneland, Anne; Vermeulen, Roel; Nieters, Alexandra; Lawrie, Charles H.; de Sanjose, Silvia.
I:
International Journal of Cancer, Bind 147, Nr. 5, 2020, s. 1315-1324.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Casabonne, D, Benavente, Y, Seifert, J, Costas, L, Armesto, M, Arestin, M, Besson, C, Hosnijeh, FS, Duell, EJ, Weiderpass, E, Masala, G, Kaaks, R, Canzian, F, Chirlaque, M-D, Perduca, V, Mancini, FR, Pala, V, Trichopoulou, A, Karakatsani, A, La Vecchia, C, Sanchez, M-J, Tumino, R, Gunter, MJ, Amiano, P, Panico, S, Sacerdote, C, Schmidt, JA, Boeing, H, Schulze, MB, Barricarte, A, Riboli, E, Olsen, A
, Tjønneland, A, Vermeulen, R, Nieters, A, Lawrie, CH & de Sanjose, S 2020, '
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study',
International Journal of Cancer, bind 147, nr. 5, s. 1315-1324.
https://doi.org/10.1002/ijc.32894
APA
Casabonne, D., Benavente, Y., Seifert, J., Costas, L., Armesto, M., Arestin, M., Besson, C., Hosnijeh, F. S., Duell, E. J., Weiderpass, E., Masala, G., Kaaks, R., Canzian, F., Chirlaque, M-D., Perduca, V., Mancini, F. R., Pala, V., Trichopoulou, A., Karakatsani, A., ... de Sanjose, S. (2020).
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.
International Journal of Cancer,
147(5), 1315-1324.
https://doi.org/10.1002/ijc.32894
Vancouver
Casabonne D, Benavente Y, Seifert J, Costas L, Armesto M, Arestin M o.a.
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.
International Journal of Cancer. 2020;147(5):1315-1324.
https://doi.org/10.1002/ijc.32894
Author
Casabonne, Delphine ; Benavente, Yolanda ; Seifert, Julia ; Costas, Laura ; Armesto, Maria ; Arestin, Maria ; Besson, Caroline ; Hosnijeh, Fatemeh S. ; Duell, Eric J. ; Weiderpass, Elisabete ; Masala, Giovanna ; Kaaks, Rudolf ; Canzian, Federico ; Chirlaque, Maria-Dolores ; Perduca, Vittorio ; Mancini, Francesca R. ; Pala, Valeria ; Trichopoulou, Antonia ; Karakatsani, Anna ; La Vecchia, Carlo ; Sanchez, Maria-Jose ; Tumino, Rosario ; Gunter, Marc J. ; Amiano, Pilar ; Panico, Salvatore ; Sacerdote, Carlotta ; Schmidt, Julie A. ; Boeing, Heiner ; Schulze, Matthias B. ; Barricarte, Aurelio ; Riboli, Elio ; Olsen, Anja ; Tjønneland, Anne ; Vermeulen, Roel ; Nieters, Alexandra ; Lawrie, Charles H. ; de Sanjose, Silvia. / Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study. I: International Journal of Cancer. 2020 ; Bind 147, Nr. 5. s. 1315-1324.
Bibtex
@article{fca5724c7fe24b57ba4275a3212fdfdc,
title = "Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study",
keywords = "chronic lymphocytic leukemia, circulating miRNA, serum, prospective study",
author = "Delphine Casabonne and Yolanda Benavente and Julia Seifert and Laura Costas and Maria Armesto and Maria Arestin and Caroline Besson and Hosnijeh, {Fatemeh S.} and Duell, {Eric J.} and Elisabete Weiderpass and Giovanna Masala and Rudolf Kaaks and Federico Canzian and Maria-Dolores Chirlaque and Vittorio Perduca and Mancini, {Francesca R.} and Valeria Pala and Antonia Trichopoulou and Anna Karakatsani and {La Vecchia}, Carlo and Maria-Jose Sanchez and Rosario Tumino and Gunter, {Marc J.} and Pilar Amiano and Salvatore Panico and Carlotta Sacerdote and Schmidt, {Julie A.} and Heiner Boeing and Schulze, {Matthias B.} and Aurelio Barricarte and Elio Riboli and Anja Olsen and Anne Tj{\o}nneland and Roel Vermeulen and Alexandra Nieters and Lawrie, {Charles H.} and {de Sanjose}, Silvia",
year = "2020",
doi = "10.1002/ijc.32894",
language = "English",
volume = "147",
pages = "1315--1324",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "JohnWiley & Sons, Inc.",
number = "5",
}
RIS
TY - JOUR
T1 - Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study
AU - Casabonne, Delphine
AU - Benavente, Yolanda
AU - Seifert, Julia
AU - Costas, Laura
AU - Armesto, Maria
AU - Arestin, Maria
AU - Besson, Caroline
AU - Hosnijeh, Fatemeh S.
AU - Duell, Eric J.
AU - Weiderpass, Elisabete
AU - Masala, Giovanna
AU - Kaaks, Rudolf
AU - Canzian, Federico
AU - Chirlaque, Maria-Dolores
AU - Perduca, Vittorio
AU - Mancini, Francesca R.
AU - Pala, Valeria
AU - Trichopoulou, Antonia
AU - Karakatsani, Anna
AU - La Vecchia, Carlo
AU - Sanchez, Maria-Jose
AU - Tumino, Rosario
AU - Gunter, Marc J.
AU - Amiano, Pilar
AU - Panico, Salvatore
AU - Sacerdote, Carlotta
AU - Schmidt, Julie A.
AU - Boeing, Heiner
AU - Schulze, Matthias B.
AU - Barricarte, Aurelio
AU - Riboli, Elio
AU - Olsen, Anja
AU - Tjønneland, Anne
AU - Vermeulen, Roel
AU - Nieters, Alexandra
AU - Lawrie, Charles H.
AU - de Sanjose, Silvia
PY - 2020
Y1 - 2020
KW - chronic lymphocytic leukemia
KW - circulating miRNA
KW - serum
KW - prospective study
U2 - 10.1002/ijc.32894
DO - 10.1002/ijc.32894
M3 - Journal article
C2 - 32012253
VL - 147
SP - 1315
EP - 1324
JO - International Journal of Cancer
JF - International Journal of Cancer
SN - 0020-7136
IS - 5
ER -